CVE-2023-41088
Last modified
CVE-2023-41088 is a medium-severity vulnerability rated 6.5/10 on the CVSS scale. The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application. . EPSS estimates a 0.24% chance of exploitation in the next 30 days.
Description
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Dexma | Dexgate | 20130114 |
References
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-41088?
How severe is CVE-2023-41088?
How do I fix CVE-2023-41088?
Are you affected by CVE-2023-41088?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST